OptimizeRx Corporation (OPRX) Profit Margins
Over the twelve months to 2026-06-30, OptimizeRx Corporation (OPRX) had gross margin 73.2%, operating margin 11.1%, net margin 4.7%, free cash flow margin 18.6%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OPRXOptimizeRx CorporationFollow OPRX — free
—
Price chart with a free account
- Market cap
- 172.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | 60.2% | 50.5% | 49.8% | 56.0% | 49.1% | 57.6% | 62.8% | 55.7% | 58.1% | 62.4% | 60.0% | 64.5% | 67.3% | 73.2% | |
| Operating margin | -130.8% | -22.9% | -5.7% | -15.8% | -8.3% | -20.4% | -17.6% | 0.8% | -15.0% | -4.9% | 0.6% | -19.7% | -36.9% | -14.9% | 10.7% | 11.1% | |
| Net margin | -190.8% | -22.9% | -5.7% | -15.8% | -8.2% | -19.9% | -17.3% | 1.1% | -12.8% | -5.1% | 0.6% | -18.3% | -24.6% | -21.8% | 4.7% | 4.7% | |
| FCF margin | -48.1% | -31.5% | 24.2% | -1.0% | 7.1% | -8.3% | -12.6% | 3.6% | -7.1% | -14.8% | 0.4% | 16.7% | -11.3% | 5.1% | 16.9% | 18.6% |
USD millions · SEC XBRL
OptimizeRx Corporation — questions
- What is OptimizeRx Corporation's gross margin?
- 73.2% over the twelve months to 2026-06-30.
- What is OptimizeRx Corporation's operating margin?
- 11.1% over the twelve months to 2026-06-30.
- What is OptimizeRx Corporation's net profit margin?
- 4.7% over the twelve months to 2026-06-30.
Every figure on this page comes from OptimizeRx Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.